Rituximab as an adjunct to plasma exchan
โ
Sushama Jasti; Thomas Coyle; Teresa Gentile; Lawrence Rosales; Bernard Poiesz
๐
Article
๐
2008
๐
John Wiley and Sons
๐
English
โ 88 KB
๐ 1 views
## Abstract Idiopathic thrombotic thrombocytopenic purpura (TTP) is caused by the production of autoantibodies against the Von Willebrand factor cleaving enzyme. This provides a rationale for the use of rituximab in this disease. We report a retrospective review of 12 patients treated with rituxima